EFFICACY AND SAFETY OF SWITCHING FROM ADALIMUMAB TO SARILUMAB IN AN OPEN-LABEL EXTENSION OF A PHASE 3 MONOTHERAPY TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)

被引：0
|
作者：
Burmester, G. R. [1 ,2 ,3 ]
Fiore, S. [4 ]
Hu, C-C [4 ]
van Hoogstraten, H. [4 ]
Lee, Bong E. [5 ]
Genovese, M. C. [6 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Free Univ, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Sanofi Genzyme, Bridgewater, MA USA
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
INTERNAL MEDICINE JOURNAL | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P33
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [21] Adalimumab for nail psoriasis: Efficacy and safety from the open-label extension of a phase-3, randomized, placebo-controlled trial
    Gottlieb, Alice B.
    Elewski, Boni E.
    Okun, Martin M.
    Bagel, Jerry
    Poulin, Yves
    Gu, Yihua
    Williams, David A.
    Valdecantos, Wendell C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB33 - AB33
  • [22] EFFICACY AND SAFETY OF SARILUMAB VERSUS ADALIMUMAB IN A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MONOTHERAPY STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH INTOLERANCE OR INADEQUATE RESPONSE TO METHOTREXATE
    Burmester, G.
    Lin, Y.
    Mangan, E.
    Van Hoogstraten, H.
    Vargas, J.
    Lee, E.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 26 - 26
  • [23] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Strand, Vibeke
    Gossec, Laure
    Proudfoot, Clare W. J.
    Chen, Chieh-I
    Reaney, Matthew
    Guillonneau, Sophie
    Kimura, Toshio
    van Adelsberg, Janet
    Lin, Yong
    Mangan, Erin K.
    van Hoogstraten, Hubert
    Burmester, Gerd R.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [24] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Vibeke Strand
    Laure Gossec
    Clare W. J. Proudfoot
    Chieh-I Chen
    Matthew Reaney
    Sophie Guillonneau
    Toshio Kimura
    Janet van Adelsberg
    Yong Lin
    Erin K. Mangan
    Hubert van Hoogstraten
    Gerd R. Burmester
    Arthritis Research & Therapy, 20
  • [25] Combination of leflunomide (LEF) and methotrexate (MTX) in patients (pts) with active rheumatoid arthritis (RA) failing MTX monotherapy - An open-label extension study
    Kremer, J
    Genovese, M
    Cannon, GW
    Caldwell, J
    Cush, J
    Weisman, M
    Luggen, ME
    Kame, J
    Bensen, W
    Furst, D
    Bathon, J
    Keystone, F
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S144 - S144
  • [26] PATIENT REPORTED BENEFITS OF SARILUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN ADULT PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Strand, V.
    Gossec, L.
    Proudfoot, C.
    Chen, C.
    Reaney, M.
    Guillonneau, S.
    Kimura, T.
    van Adelsberg, J.
    Lin, Y.
    Mangan, E.
    van Hoogstraten, H.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 94 - 94
  • [27] Efficacy and Safety of Switching from Adalimumab to Baricitinib: Long-Term Data from Phase 3 Extension Study in Patients with Rheumatoid Arthritis
    Weinblatt, Michael E.
    Taylor, Peter C.
    Keystone, Edward C.
    Ortmann, Robert A.
    Issa, Maher
    Xie, Li
    de Bono, Stephanie
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] PATIENTS (PTS) SWITCHED TO SARILUMAB FROM ADALIMUMAB ACHIEVE CLINICALLY IMPORTANT IMPROVEMENTS IN RA DISEASE ACTIVITY: RESULTS FROM MONARCH TRIAL OPEN-LABEL EXTENSION (OLE)
    Burmester, Gerd Ruediger
    Amital, Howard
    Rubbert-Roth, Andrea
    van Hoogstraten, Hubert
    Gervitz, Leonm.
    Thangavelu, Karthinathan
    St John, Gregory
    Genovese, Mark C.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1138 - 1139
  • [29] Tocilizumab Monotherapy Reduces Arterial Stiffness as Effectively as Etanercept or Adalimumab Monotherapy in Rheumatoid Arthritis: An Open-label Randomized Controlled Trial
    Kume, Kensuke
    Amano, Kanzo
    Yamada, Susumu
    Hatta, Kazuhiko
    Ohta, Hiroyuki
    Kuwaba, Noriko
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (10) : 2169 - 2171
  • [30] EFFICACY AND SAFETY OF SARILUMAB IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS FROM 2 PHASE 3 STUDIES
    Genovese, Mark C.
    Fleischmann, Roy
    Mangan, Erin K.
    van Adelsberg, Janet
    Iglesias-Rodriguez, Melitza
    Fan, Chunpeng
    Huizinga, Tom W.
    RHEUMATOLOGY, 2017, 56 : 137 - 138
12345